February 02, 2017
CHAIRES et al v. NOVO NORDISK INC. et al
Case Number:
3:17-cv-00699
Court:
Nature of Suit:
Racketeer/Corrupt Organization
Multi Party Litigation:
Class Action
Judge:
Firms
- Alston & Bird
- Carella Byrne
- Chiesa Shahinian
- Cohn Lifland
- Covington & Burling
- Critchley Kinum
- Faegre Drinker
- Gibbons PC
- Kessler Topaz
- Marino Tortorella
- McCarter & English
- McElroy Deutsch
- Miller Shah LLP
- O'Toole Scrivo
- Reed Smith
- Walsh Pizzi
- Weitz & Luxenberg
Companies
- CVS Health Corp.
- Eli Lilly & Co.
- Express Scripts Holding Co.
- Novo Nordisk A S
- Optum Inc.
- OptumRx Inc.
- Rochester Drug Cooperative Inc.
- Sanofi
- UnitedHealth Group Inc.
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
May 26, 2023
Lilly To Pay $13M, Cap Insulin Cost In Deal Worth Up To $500M
Insulin buyers asked a New Jersey federal judge Friday to greenlight a class settlement with Eli Lilly & Co. resolving claims it schemed to drive up insulin drug prices, a deal that includes $13.5 million cash and insulin price caps which plaintiffs' lawyers value at $500 million over four years.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login